Researchers have carried out a systematic review and meta-analysis to determine which chronic conditions put hospitalised patients at risk of dying from Covid-19.
They explored 11 co-existing conditions that pose a risk of severe disease and death among Covid-19 patients, including cardiovascular disease, diabetes, high blood pressure, cancer, chronic kidney disease, chronic obstructive pulmonary disease, stroke, congestive heart failure, asthma, chronic liver disease, and HIV/AIDS.
Researchers determined that patients with diabetes and cancer are 1.5 times more likely to die. Patients with cardiovascular disease, hypertension, and congestive heart failure are twice as likely to die. While patients with chronic kidney disease are three times more likely to die.
Eminent Indian-origin academician Srikant Datar has been named as Dean of Harvard Business School, succeeding Nitin Nohria and becoming the second consecutive dean hailing from India to lead the prestigious 112-year-old institution.
Datar, an alumnus of University of Bombay and Indian Institute of Management, Ahmedabad, is the Arthur Lowes Dickinson Professor of Business Administration and the senior associate dean for University Affairs at Harvard Business School (HBS).
A chartered accountant, he went on to receive a postgraduate diploma in business management from the Indian Institute of Management, Ahmedabad, before completing master's degrees in statistics and economics and a Ph.D. in business from Stanford University.